National Pharmaceutical Regulatory Agency NPRA director Dr Roshayati Mohamad Sani said they were part of the 58 reports on adverse effects of immunisation AEFI involving deaths among booster dose vaccine recipients that were received as of April 22 for investigation and evaluation.
The majority of the AEFI reported were for non-serious events, primarily fever, pain at injection site, headache, and muscle aches, which typically resolve within two days.
At the time of writing, the is now showing a pop-up that says that the website is no longer updated after 90% of total adults in Malaysia have been vaccinated.